The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?
A Jurj, C Ionescu, I Berindan-Neagoe… - Journal of Experimental & …, 2022 - Springer
The extracellular matrix (ECM) is an important component of the tumor microenvironment
(TME), having several important roles related to the hallmarks of cancer. In cancer, multiple …
(TME), having several important roles related to the hallmarks of cancer. In cancer, multiple …
Immunotherapy in biliary tract cancers: current standard-of-care and emerging strategies
JH Lo, R Agarwal, LW Goff, TR Heumann - Cancers, 2023 - mdpi.com
Simple Summary Biliary tract cancers (BTCs), comprising cancers of the bile ducts
(cholangiocarcinoma) as well as gallbladder cancers, continue to be challenging to treat …
(cholangiocarcinoma) as well as gallbladder cancers, continue to be challenging to treat …
Regression-based Deep-Learning predicts molecular biomarkers from pathology slides
Deep Learning (DL) can predict biomarkers from cancer histopathology. Several clinically
approved applications use this technology. Most approaches, however, predict categorical …
approved applications use this technology. Most approaches, however, predict categorical …
The immune landscape of colorectal cancer
A Mezheyeuski, P Micke, A Martin-Bernabe… - Cancers, 2021 - mdpi.com
Simple Summary We sought to provide a detailed overview of the immune landscape of
colorectal cancer in the largest study to date in terms of patient numbers and analyzed …
colorectal cancer in the largest study to date in terms of patient numbers and analyzed …
An immune score reflecting pro-and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid …
A Mezheyeuski, M Backman, J Mattsson… - …, 2023 - thelancet.com
Background Cancer immunity is based on the interaction of a multitude of cells in the spatial
context of the tumour tissue. Clinically relevant immune signatures are therefore anticipated …
context of the tumour tissue. Clinically relevant immune signatures are therefore anticipated …
miR-15a and miR-15b modulate natural killer and CD8+ T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma
AS Pathania, P Prathipati, OA Olwenyi, S Chava… - Molecular Therapy …, 2022 - cell.com
Neuroblastoma (NB) is an enigmatic and deadliest pediatric cancer to treat. The major
obstacles to the effective immunotherapy treatments in NB are defective immune cells and …
obstacles to the effective immunotherapy treatments in NB are defective immune cells and …
Tumor-stroma proportion to predict chemoresistance in patients with ovarian cancer
IMPORTANCE Platinum-based chemotherapy is the backbone of standard-of-care treatment
for patients with advanced-stage, high-grade serous carcinoma (HGSC), the most common …
for patients with advanced-stage, high-grade serous carcinoma (HGSC), the most common …
Engineering heterogeneous tumor models for biomedical applications
Tumor tissue engineering holds great promise for replicating the physiological and
behavioral characteristics of tumors in vitro. Advances in this field have led to new …
behavioral characteristics of tumors in vitro. Advances in this field have led to new …
TIMP1 is an early biomarker for detection and prognosis of lung cancer
Background Lung cancer remains the major cause of cancer‐related deaths worldwide.
Early stages of lung cancer are characterized by long asymptomatic periods that are …
Early stages of lung cancer are characterized by long asymptomatic periods that are …
Bête noire of chemotherapy and targeted therapy: CAF-mediated resistance
P De, J Aske, R Sulaiman, N Dey - Cancers, 2022 - mdpi.com
Simple Summary Tumor cells struggle to survive following treatment. The struggle ends in
either of two ways. The drug combination used for the treatment blocks the proliferation of …
either of two ways. The drug combination used for the treatment blocks the proliferation of …